Biobanco de donantes del centro de Hemoterapia de Castilla y León, Spain

Registration Status: Completed

Objective: We aim to provide a quality public service in the activities it carries out. - To be a regional benchmark in the collection of samples from healthy donors. - To respect the harmonization of procedures, institutional integration, and organization as a public service for samples and associated data within the framework of the law. - To guarantee a strong commitment to its own ethical principles and strict compliance with current regulations. - To prevent the illicit trafficking of biological materials of human origin.

Registered Biobank Name	Biobanco de donantes del centro de Hemoterapia de Castilla y León
Biobank Leader	Martín Alonso, Mª del Carmen
Country	Spain
Email for biobank inquiries	cmartinalo@saludcastillayleon.es
Principal Investigator	Martín Alonso, Mª del Carmen
Website
User Type Mono: A biobank that supports a specific research project, may have few staff members, a small-scale accrual scope with little to no initial intention of releasing or distributing biospecimens to secondary parties Oligo: A biobank that supports several research groups or clinical trials, may or may not be designed to release biospecimens outside their collaborative group Poly: A biobank that has generally a larger accrual scope, resources, and multiple users outside the biobank proper

Biospecimen Collected:

Cohort Highlights

100 cases Next Generation Sequencing assay to detect all classes of genetic variant in Lung Cancer using a single Diagnostic test.
200 cases Colorectal TMA for QC purposes in support of study of tumor infiltrating lymphocytes in ovarian cancer tissues.
Build 300 cases breast cancer TMA containing primary tumour and matched metastatic LN for various subtypes (luminal, HER2, Triple negative). Start with Triple negatives.
125 cases Breast tumour and metastatic lymph nodes in breast cancer cases with outcomes of metastasis to lung or bone.
100 cases of rare tumours - fibrolamellar hepatocellular carcinoma. FFPE, frozen, BC.
200 cases of FFPE tissue sections from breast, lung adenocarcinoma, and lung squamous cell carcinoma with matching normal tissue (only pathology data requested).